Roberton A M, Mantle M, Fahim R E, Specian R D, Bennick A, Kawagishi S, Sherman P, Forstner J F
Department of Biochemistry, University of Auckland, Private Bag, New Zealand.
Biochem J. 1989 Jul 15;261(2):637-47. doi: 10.1042/bj2610637.
The existence of a discrete 'link' peptide in epithelial mucins has been debated for many years. There is evidence that at least some mucins contain a specific 'link' peptide (or glycopeptide) that enhances mucin polymerization by forming disulphide bridges to large mucin glycoprotein subunits. A major difficulty has been to know whether the reported differences in putative 'link' components represent artifacts generated by inter-laboratory differences in technical procedures used in mucin purification. The present paper outlines the results of a collaborative study involving five laboratories and 53 samples of purified gastrointestinal mucins (including salivary, gastric, small-intestinal and colonic mucins) prepared by five techniques from four different animal species. An early step in mucin purification in all cases was the addition of proteinase inhibitors. Representative mucins were analysed for their composition, electrophoretic mobility in SDS/polyacrylamide-gel electrophoresis before and after disulphide-bond reduction, and for their reactivity with monospecific antibodies developed against the 118 kDa putative 'link' glycopeptide isolated from either rat or human small-intestinal mucins. Our results indicate that, despite differences in laboratory techniques, preparative procedures, organs and species, each of the purified mucins contained a 'link' component that was released by disulphide-bond reduction and produced a band on SDS/polyacrylamide-gel electrophoresis at a position of approx. 118 kDa. After electroelution and analyses, the 118 kDa bands from the different mucins were found to have similar amino acid profiles and to contain carbohydrate. It would appear therefore that a 'link' glycopeptide of molecular mass approx. 118 kDa is common to all of the gastrointestinal mucins studied.
上皮粘蛋白中离散“连接”肽的存在已争论多年。有证据表明,至少某些粘蛋白含有特定的“连接”肽(或糖肽),该肽通过与大的粘蛋白糖蛋白亚基形成二硫键来增强粘蛋白聚合。一个主要困难在于,要确定所报道的假定“连接”成分的差异是否代表了粘蛋白纯化过程中实验室技术差异所产生的假象。本文概述了一项合作研究的结果,该研究涉及五个实验室以及通过五种技术从四种不同动物物种制备的53份纯化胃肠道粘蛋白样本(包括唾液、胃、小肠和结肠粘蛋白)。在所有情况下,粘蛋白纯化的早期步骤都是添加蛋白酶抑制剂。对代表性粘蛋白进行了成分分析、二硫键还原前后在SDS/聚丙烯酰胺凝胶电泳中的电泳迁移率分析,以及与针对从大鼠或人小肠粘蛋白中分离出的118 kDa假定“连接”糖肽制备的单特异性抗体的反应性分析。我们的结果表明,尽管实验室技术、制备程序、器官和物种存在差异,但每种纯化的粘蛋白都含有一种“连接”成分,该成分可通过二硫键还原释放出来,并在SDS/聚丙烯酰胺凝胶电泳上约118 kDa的位置产生一条带。经过电洗脱和分析后,发现来自不同粘蛋白的118 kDa条带具有相似的氨基酸谱并含有碳水化合物。因此,分子量约118 kDa的“连接”糖肽似乎是所有研究的胃肠道粘蛋白所共有的。